Facebook Linkedin RSS Twitter Youtube
Home 2022

Protein degradation

CMS Enables Standard-Free Quantitation of Protein Therapeutics
Bioprocessing

CMS Enables Standard-Free Quantitation of Protein Therapeutics

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings
Cancer

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings

DMPK Optimization of Proteolysis-Targeting Chimeras
Drug Discovery

DMPK Optimization of Proteolysis-Targeting Chimeras

Novartis Jumpstarts Presence in Protein Degradation with Up-to-$1.3B Dunad Collaboration
Drug Discovery

Novartis Jumpstarts Presence in Protein Degradation with Up-to-$1.3B Dunad Collaboration

Expanding the Druggable Space to Accelerate Lead Identification
Drug Discovery

Expanding the Druggable Space to Accelerate Lead Identification

Heavyweight Division: Arvinas Paves the Way for Therapeutics That Degrade Disease-Related Proteins
Drug Discovery

Heavyweight Division: Arvinas Paves the Way for Therapeutics That Degrade Disease-Related Proteins

Targeted Protein Degradation Represents a Promising Therapeutic Strategy
Drug Discovery

Targeted Protein Degradation Represents a Promising Therapeutic Strategy

New Role for MafB Protein in Protecting against Kidney Disease
News

New Role for MafB Protein in Protecting against Kidney Disease

Assessing Antibody Aggregation
Bioprocessing

Assessing Antibody Aggregation

Pfizer Joins Yale Spinout in Up-to-$830M Protein Degradation Drug Collaboration
Industry News

Pfizer Joins Yale Spinout in Up-to-$830M Protein Degradation Drug Collaboration

123Page 2 of 3
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.